Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Non Operating Income (2019 - 2025)

Volitionrx's Non Operating Income history spans 7 years, with the latest figure at -$1.5 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 1856.14% year-over-year to -$1.5 million; the TTM value through Dec 2025 reached -$1.8 million, down 657.22%, while the annual FY2025 figure was -$1.8 million, 657.36% down from the prior year.
  • Non Operating Income reached -$1.5 million in Q4 2025 per VNRX's latest filing, down from -$308801.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $676795.0 in Q4 2021 to a low of -$1.5 million in Q4 2025.
  • Average Non Operating Income over 5 years is $41904.0, with a median of -$1056.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: surged 519.5% in 2023, then crashed 239480.62% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $676795.0 in 2021, then dropped by 0.34% to $674476.0 in 2022, then tumbled by 108.77% to -$59126.0 in 2023, then fell by 28.35% to -$75887.0 in 2024, then plummeted by 1856.14% to -$1.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Non Operating Income are -$1.5 million (Q4 2025), -$308801.0 (Q3 2025), and -$16263.0 (Q2 2025).